Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
6.32
+0.01 (0.16%)
Jun 18, 2026, 4:00 PM EDT - Market closed
Aura Biosciences Market Cap
Aura Biosciences has a market cap or net worth of $697.09 million as of June 18, 2026. Its market cap has increased by 83.10% in one year.
Market Cap
697.09M
Enterprise Value
585.01M
1-Year Change
83.10%
Ranking
Category
Stock Price
$6.32
Market Cap Chart
Since the IPO on October 29, 2021, Aura Biosciences's market cap has increased from $397.73M to $697.09M, an increase of 75.27%. That is a compound annual growth rate of 12.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 697.09M | 101.42% |
| Dec 31, 2025 | 346.09M | -15.71% |
| Dec 31, 2024 | 410.60M | -5.92% |
| Dec 29, 2023 | 436.44M | 12.22% |
| Dec 30, 2022 | 388.92M | -21.59% |
| Dec 31, 2021 | 496.00M | 24.71% |
| Oct 29, 2021 | 397.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zevra Therapeutics | 745.44M |
| Design Therapeutics | 745.11M |
| Evommune | 743.78M |
| Solid Biosciences | 719.67M |
| Tenax Therapeutics | 698.89M |
| Omeros | 697.70M |
| Relmada Therapeutics | 690.18M |
| Oculis Holding AG | 682.39M |